Literature DB >> 22377939

Effect of hyperoxic-supplemented interval training on endurance performance in trained cyclists.

A E Kilding1, M Wood, G Sequira, D L Bonetti.   

Abstract

The aim of this study was to determine the effect of hyperoxic-supplemented interval training on endurance performance. Using a single-blind, randomised control-trial design, 16 well-trained cyclists were randomly assigned to either hyperoxic or normoxic training. Participants visited the laboratory twice per week, for 4 weeks, to perform high-intensity interval training sessions. A 20 km TT, incremental exercise test and 60s all-out test were conducted pre- and post-intervention. Smaller effects for most physiological measures, including VO 2peak (1.9 ± 4.3%) and lactate threshold (0.3 ± 8.3%), were observed after training in hyperoxia compared to normoxia. There was a small increase in mean power during the 20 km TT after hyperoxia [2.1 ± 3.7%; effect size (ES): - 0.30 ± 0.39] but this was less than that observed after normoxia (4.9 ± 3.9%; ES: - 0.44 ± 0.60). During the 60 s all-out test, the peak relative power was relatively unchanged, whereas mean relative power was increased in normoxia (2.3 ± 3.4%) but not hyperoxia (0.3 ± 1.2%; ES: - 0.34 ± 0.49). Hyperoxic-supplemented interval training in the competitive season had less effect on endurance and high-intensity performance and physiology in trained endurance cyclists compared to interval training in normoxia. Therefore hyperoxic-supplemented training at sea level appears to be not worthwhile for maximising performance in competitive endurance athletes. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2012        PMID: 22377939     DOI: 10.1055/s-0031-1297999

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  1 in total

Review 1.  The Impact of Hyperoxia on Human Performance and Recovery.

Authors:  Billy Sperlich; Christoph Zinner; Anna Hauser; Hans-Christer Holmberg; Jennifer Wegrzyk
Journal:  Sports Med       Date:  2017-03       Impact factor: 11.136

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.